Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial to evaluate safety, tolerability, and pharmacokinetics of RSN0402 in healthy volunteers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• RSN0402

Snippet

Sponsor: Shenzhen Resproly Biopharmaceutical Co., Ltd | Conditions: Idiopathic Pulmonary Fibrosis, Lung; Disease, Interstitial, With Fibrosis | Phase 1 | Status: RECRUITING